Boston, Massachusetts is the undisputed biopharma and clinical oncology capital of the world. Dana-Farber / Harvard Cancer Center, Mass General, and Boston Children's lead the world in new drug discovery and pediatric cure rates. Learn about top NCI institutions, leading hospital networks, clinical trials, and patient navigation in Massachusetts.
Boston, Massachusetts
More than 1,000 active clinical trials across Dana-Farber, Mass General, and Harvard teaching hospitals.
Dana-Farber Cancer Institute and Massachusetts General Hospital Cancer Center in Boston are consistently ranked among the top 3 cancer institutions in the United States.
Yes. ByOnco matches national and international patients to Dana-Farber and MGH oncologists, organizes rapid multidisciplinary second opinions, and coordinates clinical record transfers.
Connect with our clinical navigation team to verify center in-network status, organize second opinions, and review clinical trials.
Essential cookies run the site. Optional analytics help us improve. Manage choices anytime in Cookie Settings. See our Privacy Policy and Cookie Policy.